HORIZON-HLTH-2022-STAYHLTH-02
HORIZON-HLTH-2022-STAYHLTH-02
- Programme
- HORIZON
- Funded projects (dataset)
- 13
- EU contribution (sum)
- €90,063,464
- Portal deadline
- —
Leading topic in historical projects: HORIZON-HLTH-2022-STAYHLTH-02-01
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN2 coordinated
- INSERM2 coordinated
- ARISTOTLE UNIVERSITY OF THESSALONIKI1 coordinated
- INCLIVA1 coordinated
- HUS1 coordinated
- I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO1 coordinated
- INSTITUT GUSTAVE ROUSSY1 coordinated
- SPINDOX LABS SRL1 coordinated
- UNIVERSITY OF TURKU1 coordinated
- UCM1 coordinated
- UNIVERSITÄTSKLINIKUM SCHLESWIG-HOLSTEIN1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- ERASMUS MC3 topic projects
- KI3 topic projects
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN2 topic projects
- CSIC2 topic projects
- EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH2 topic projects
- IDIBAPS-CERCA2 topic projects
- HELSINGIN YLIOPISTO2 topic projects
- HOSPITAL CLINIC DE BARCELONA2 topic projects
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2 topic projects
- INSERM TRANSFERT SA2 topic projects
- INTERNATIONAL FEDERATION OF CROHNS AND ULCERATIVE COLITIS ASSOCIATIONS2 topic projects
- LU2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- INSERM · INSERM TRANSFERT SA2 shared
FR ↔ FR
- 2 shared
- 2 shared
- SERMAS · IDIBAPS-CERCA2 shared
ES ↔ ES
- 2 shared
- KI · INSERM TRANSFERT SA2 shared
SE ↔ FR
- EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH · RESEARCH AND INNOVATION SERVICES DOO ZA USLUGE2 shared
DE ↔ HR
- 2 shared
- HOSPITAL CLINIC DE BARCELONA · SERMAS2 shared
ES ↔ ES
- 2 shared
- 1 shared
- AINIGMA · FACULDADE DE MOTRICIDADE HUMANA1 shared
BE ↔ PT
- AINIGMA · SMARTSOL SIA1 shared
BE ↔ LV
- 1 shared
- 1 shared
- AINIGMA · NETCOMPANY-INTRASOFT SA1 shared
BE ↔ LU
- 1 shared
- 1 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 13.54
- Median orgs / project
- 13
- Min / max orgs
- 10 – 23
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- France22
- Spain21
- Germany19
- Italy16
- Portugal14
- Belgium9
- Netherlands9
- Sweden9
- United Kingdom8
- Switzerland6
- Finland6
- Greece4
- Latvia4
- Israel4
- United States4
- Denmark3
- Croatia3
- Austria3
Organization types
- university62 orgs · 74 rows
- research_institute35 orgs · 43 rows
- sme28 orgs · 30 rows
- company13 orgs · 14 rows
- other7 orgs · 8 rows
- public_body6 orgs · 7 rows
Topics in funded projects
- HORIZON-HLTH-2022-STAYHLTH-02-01HORIZON-HLTH-2022-STAYHLTH-02-01· 13 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| INTERCEPT-T2D Early Interception of Inflammatory-mediated Type 2 Diabetes | HORIZON | €8,689,222 |
| INITIALISE Inflammation in human early life: targeting impacts on life-course health | HORIZON | €7,451,044 |
| PROTO PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES | HORIZON | €7,447,875 |
| miGut-Health Personalised blueprint intestinal health | HORIZON | €7,126,244 |
| PREVALUNG EU Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception. | HORIZON | €7,016,124 |
| ENDOTARGET Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic targets for Arthritis | HORIZON | €6,997,820 |
| CARE-IN-HEALTH CArdiovascularREsolution of INflammation to promote HEALTH | HORIZON | €6,993,396 |
| GlycanTrigger GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION | HORIZON | €6,771,571 |
| halt-RONIN Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies | HORIZON | €6,721,927 |
| iPROLEPSIS iPROLEPSIS: PSORIATIC ARTHRITIS INFLAMMATION EXPLAINED THROUGH MULTI-SOURCE DATA ANALYSIS GUIDING A NOVEL PERSONALISED DIGITAL CARE ECOSYSTEM | HORIZON | €6,483,091 |
| AIDA An Artificially Intelligent Diagnostic Assistant for gastric inflammation | HORIZON | €6,334,804 |
| IMMEDIATE Imminent Disease Prediction and Prevention at the Environment Host Interface | HORIZON | €6,221,606 |
| PRAESIIDIUM PHYSICS INFORMED MACHINE LEARNING-BASED PREDICTION AND REVERSION OF IMPAIRED FASTING GLUCOSE MANAGEMENT | HORIZON | €5,808,740 |